The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TALAPRO-2: a placebo-controlled phase III study of talazoparib (TALA) plus enzalutamide (ENZA) for patients with first-line metastatic castration-resistant prostate cancer (mCRPC).
 
Neeraj Agarwal
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bristol-Myers Squibb; Exelixis; Foundation Medicine; Foundation One Inc; Janssen Oncology; Lilly; Lilly; Lilly; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer; Pfizer; Pharmacyclics
Research Funding - Active Biotech (Inst); Amgen (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Neal D. Shore
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Merck; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen
 
Curtis Dunshee
Consulting or Advisory Role - Ferring; Genzyme; Pfizer
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Dendreon (Inst); Eleven Biotherapeutics (Inst); Exact Sciences (Inst); Ferring (Inst); Janssen Oncology (Inst); Myovant Sciences (Inst); pfizer (Inst); Siemens (Inst); TesoRX Pharmaceuticals (Inst)
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical (I)
Honoraria - 3D Biopsy; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Dendreon; Foundation Medicine; Genomic Health; Janssen; Merck; Myriad Pharmaceuticals; Pfizer; Urogen pharma
Consulting or Advisory Role - 3D Biopsy; Abbvie; Astellas Pharma; Augmenix; Bayer; Dendreon; Ferring; Janssen; Pfizer; Precision Biopsy; Spectrum Pharmaceuticals
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Augmenix (Inst); Bayer (Inst); CU Optics (Inst); Dendreon (Inst); Exact Sciences (Inst); Ferring (Inst); FKD Therapies (Inst); Genomic Health (Inst); Janssen (Inst); Merck (Inst); Myovant Sciences (Inst); Nucleix (Inst); Nymox (Inst); OPKO Biologics (Inst); Pfizer (Inst); Precision Biopsy (Inst); PrecisionMed (Inst); Roche (Inst); Siemens (Inst); Spectrum Pharmaceuticals (Inst); Urogen pharma (Inst); Veru (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; dendreon; Foundation Medicine; Janssen; Pfizer; Spectrum Pharmaceuticals
 
Arun Azad
Honoraria - Amgen; Astellas Pharma; Bayer; Janssen; Novartis; Pfizer; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Merck Serono; Sanofi
 
Andre P. Fay
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Joan Carles
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson; MSD Oncology; Pfizer; Roche; Sanofi
Speakers' Bureau - Asofarma; Astellas Pharma; Bayer; Johnson & Johnson
Research Funding - AB Science (Inst); Aragon Pharmaceuticals (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); BN ImmunoTherapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen-Cilag (Inst); Karyopharm Therapeutics (Inst); Leurquin Mediolanum (Inst); Lilly (Inst); Medimmune (Inst); Millennium (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi/Aventis (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AstraZéneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Roche (Inst)
 
M. Luisa Paccagnella
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Nicola Di Santo
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Mohamed Elmeliegy
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Xun Lin
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Ruben G.W. Quek
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Akos Czibere
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Karim Fizazi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma; AstraZeneca (Inst); Bayer; Curevac (Inst); ESSA (Inst); Janssen Oncology; Orion; Sanofi
Travel, Accommodations, Expenses - Amgen; Janssen